112 related articles for article (PubMed ID: 16955283)
1. Insulin sensitization induced by oral cicletanine in conscious rabbits.
Peitl B; Németh J; Pankucsi C; Szilvássy Z
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):429-39. PubMed ID: 16955283
[TBL] [Abstract][Full Text] [Related]
2. Beneficial cardiac effects of cicletanine in conscious rabbits with metabolic syndrome.
Drimba L; Hegedüs C; Yin D; Sári R; Németh J; Szilvássy Z; Peitl B
J Cardiovasc Pharmacol; 2012 Aug; 60(2):208-18. PubMed ID: 22622233
[TBL] [Abstract][Full Text] [Related]
3. Neurogenic insulin resistance in guinea-pigs with cisplatin-induced neuropathy.
Szilvássy J; Sziklai I; Sári R; Németh J; Peitl B; Porszasz R; Lonovics J; Szilvássy Z
Eur J Pharmacol; 2006 Feb; 531(1-3):217-25. PubMed ID: 16438961
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine.
Szilvássy Z; Csont T; Páli T; Droy-Lefaix MT; Ferdinandy P
J Vasc Res; 2001; 38(1):39-46. PubMed ID: 11173993
[TBL] [Abstract][Full Text] [Related]
5. Cicletanine attenuates overdrive pacing-induced global myocardial ischemia in rabbits: possible role of cardiac cyclic nucleotides.
Szilvassy Z; Jakab I; Bor P; Koltai M; Tarrade T; Esanu A; Braquet PG; Lonovics J
Coron Artery Dis; 1993 May; 4(5):443-52. PubMed ID: 8261221
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.
Silver PJ; O'Connor B; Cumiskey WR; Van Aller G; Hamel LT; Bentley RG; Pagani ED
J Pharmacol Exp Ther; 1991 Apr; 257(1):382-91. PubMed ID: 1850474
[TBL] [Abstract][Full Text] [Related]
7. The sensory nitrergic nature of the hepatic insulin sensitizing substance mechanism in conscious rabbits.
Porszasz R; Legvari G; Nemeth J; Literati PN; Szolcsanyi J; Szilvassy Z
Eur J Pharmacol; 2002 May; 443(1-3):211-2. PubMed ID: 12044813
[TBL] [Abstract][Full Text] [Related]
8. T-1032, a cyclic GMP phosphodiesterase-5 inhibitor, acutely blocks physiologic insulin-mediated muscle haemodynamic effects and glucose uptake in vivo.
Mahajan H; Richards SM; Rattigan S; Clark MG
Br J Pharmacol; 2003 Dec; 140(7):1283-91. PubMed ID: 14581178
[TBL] [Abstract][Full Text] [Related]
9. Zaprinast, cicletanine, and verapamil attenuate overdrive pacing-induced myocardial ischemia in conscious rabbits.
Szilvassy Z; Jakab I; Ferdinandy P; Koltai M; Lonovics J; Tarrade T; Braquet PG
Life Sci; 1993; 53(1):PL13-8. PubMed ID: 8390593
[TBL] [Abstract][Full Text] [Related]
10. Hepatic insulin sensitizing substance: a novel 'sensocrine' mechanism to increase insulin sensitivity in anaesthetized rats.
Porszasz R; Legvari G; Pataki T; Szilvassy J; Nemeth J; Kovacs P; Paragh G; Szolcsanyi J; Szilvassy Z
Br J Pharmacol; 2003 Jul; 139(6):1171-9. PubMed ID: 12871836
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of low Km cyclic GMP phosphodiesterases and potentiation of guanylate cyclase activators by cicletanine.
Silver PJ; Buchholz A; Dundore RL; Harris AL; Pagani ED
J Cardiovasc Pharmacol; 1990 Sep; 16(3):501-5. PubMed ID: 1700224
[TBL] [Abstract][Full Text] [Related]
12. Effect of cicletanine on renal cGMP production.
Valdivielso JM; Morales AI; Pérez-Barriocanal F; López-Novoa JM
Can J Physiol Pharmacol; 1998 Dec; 76(12):1151-5. PubMed ID: 10326838
[TBL] [Abstract][Full Text] [Related]
13. Effect of cicletanine on the nitric oxide pathway in human umbilical vein endothelial cells.
Akamatsu N; Sawada S; Komatsu S; Tamagaki T; Hiranuma O; Kawahara T; Tsuda Y; Kono Y; Higaki T; Tada Y; Yamasaki S; Imamura H; Sato T; Tsuji H; Nakagawa M
J Cardiovasc Pharmacol; 2001 Aug; 38(2):174-82. PubMed ID: 11483866
[TBL] [Abstract][Full Text] [Related]
14. Block by nitrate tolerance of meal-induced insulin sensitization in conscious rabbits.
Bajza A; Németh J; Peitl B; Szilvássy Z
J Cardiovasc Pharmacol; 2011 Nov; 58(5):508-13. PubMed ID: 21765367
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver.
Guarino MP; Correia NC; Lautt WW; Macedo MP
Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G527-32. PubMed ID: 15331351
[TBL] [Abstract][Full Text] [Related]
16. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.
Méry PF; Pavoine C; Pecker F; Fischmeister R
Mol Pharmacol; 1995 Jul; 48(1):121-30. PubMed ID: 7623766
[TBL] [Abstract][Full Text] [Related]
17. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF
Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical methods for the determination of insulin sensitivity.
Zsuga J; Tory K; Jaszlits L; Bajza A; Nemeth J; Peitl B; Szilvassy Z
J Biochem Biophys Methods; 2004 Oct; 61(1-2):253-8. PubMed ID: 15560942
[TBL] [Abstract][Full Text] [Related]
19. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
Mushlin P; Boerth RC; Wells JN
Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
[No Abstract] [Full Text] [Related]
20. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ; Ong MK; Lutterman JA; Smits P
Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
